Company: ICUI
Filing Date: 2025-11-06
Form Type: 10-Q
Source: 0000883984-25-000035
Chunk: 65

Company: ICU MEDICAL INC/DE
Filing Date: 2025-11-06
Form: 10-Q
Item: Item 1
Chunk 65
---
 liabilities$2,024$1,066Other long-term liabilities3,9872,332Total finance lease liabilities$6,011$3,398Weighted-Average Remaining Lease TermFinance leases3.2 years3.5 yearsWeighted-Average Discount RateFinance leases6.24 %5.63 %            As of September 30, 2025, the maturities of our operating and finance lease liabilities for each of the next five years and thereafter are approximately (in thousands):Operating LeasesFinance LeasesRemainder of 2025$4,251 $595 202615,530 2,298 202712,382 1,905 20289,671 1,369 20297,804 394 20304,628 52 Thereafter16,542 — Total Lease Payments70,808 6,613 Less imputed interest(10,632)(602)Total$60,176 $6,011 

Note 8:    Net (Loss) Income Per Share

 Basic net (loss) income per share is computed by dividing net (loss) income by the weighted-average number of common shares outstanding during the period. Diluted (loss) income per share is computed by dividing net (loss) income by the weighted-average number of common shares outstanding during the period plus dilutive securities. Dilutive securities include outstanding common stock options and unvested restricted stock units, less the number of shares that could have been purchased with the proceeds from the exercise of the options, using the treasury stock method. Options and restricted stock units that are anti-dilutive are not included in the treasury stock method calculation. A net loss for the three months ended September 30, 2025 and 2024 and nine months ended September 30, 2024 causes all of the potentially dilutive common shares to be antidilutive and, accordingly, they were not included in the computation of diluted earnings per share, and basic and diluted net loss per share are equal for each of these periods.    The following table presents the calculation of net earnings per common share (“EPS”) — basic and diluted (in thousands, except per share data):  

20

ICU MEDICAL, INC. AND SUBSIDIARIESNOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS(Continued)

 Three months ended September 30,Nine months ended September 30, 202520